Arax Advisory Partners’s Zymeworks ZYME Stock Holding History
Bought
Maintained
Sold
Other funds holding ZYME
Arax Advisory Partners's ZYME Position: Q3 2026 in Review
Arax Advisory Partners increased its Zymeworks (ZYME) stake by 6.4% in Q3 2026, buying an estimated $4.95K and bringing the position to 3,189 shares worth $84.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2940.
Arax Advisory Partners first reported a position in ZYME in Q2 2024 and has held it in 7 quarters since. 203 funds tracked by Wall St. Rank hold ZYME as of Q3 2026.
- Arax Advisory Partners held 3,189 shares of Zymeworks worth $84.5K as of Q3 2026.
- Arax Advisory Partners bought 191 Zymeworks shares in Q3 2026, an estimated $4.95K.
- Zymeworks made up ﹤0.01% of Arax Advisory Partners's portfolio in Q3 2026, its #2940 holding.
- Arax Advisory Partners first reported a position in Zymeworks in Q2 2024 and has held it in 7 quarters since.
- 203 funds tracked by Wall St. Rank held Zymeworks as of Q3 2026.
Based on Arax Advisory Partners's 13F filing for Q3 2026, filed 12 Nov 2026.